[go: up one dir, main page]

MX2023005387A - Cristales de maleato de forma-ii de (s)-n2-[1-(4-fluorofenil)etil] -4-(1-metil-1h-pirazol-4-il)-n6-(pirazin-2-il)piridina-2,6-diamin a. - Google Patents

Cristales de maleato de forma-ii de (s)-n2-[1-(4-fluorofenil)etil] -4-(1-metil-1h-pirazol-4-il)-n6-(pirazin-2-il)piridina-2,6-diamin a.

Info

Publication number
MX2023005387A
MX2023005387A MX2023005387A MX2023005387A MX2023005387A MX 2023005387 A MX2023005387 A MX 2023005387A MX 2023005387 A MX2023005387 A MX 2023005387A MX 2023005387 A MX2023005387 A MX 2023005387A MX 2023005387 A MX2023005387 A MX 2023005387A
Authority
MX
Mexico
Prior art keywords
degrees
sup
compound
cukî
radiation
Prior art date
Application number
MX2023005387A
Other languages
English (en)
Inventor
Toshio Fujiwara
Joanna Bis
Kusalakumari Sukumar Senthil Kumar
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65901897&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2023005387(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of MX2023005387A publication Critical patent/MX2023005387A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/145—Maleic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Un objeto principal de la presente invención es proporcionar nuevos cristales de (S)-N2-[1-(4-fluorofenil)etil]-4-(1-metil-1H-p irazol-4-il)-N6-(pirazin-2-il)piridina-2,6-diamina maleato (en lo sucesivo, referido como el "compuesto A"). Un cristal de Forma-I del compuesto A, que muestra picos de difracción en su espectro de difracción de polvo de rayos-X en al menos los siguientes ángulos de difracción 2?: 6.9 grados, 9.4 grados, 12.5 grados, 15.1 grados, 16.4 grados, 18.3 grados, 19.0 grados, 24.9 grados, 25.4 grados, 27.3 grados, y 27.7 grados, en donde espectro de difracción de polvo de rayos-X se obtiene al utilizar radiación Cu Ka (?=1.54Å). Un cristal de Forma-II del compuesto A, que muestra picos de difracción en su espectro de difracción de polvo de rayos-X en al menos los siguientes ángulos de difracción 2?: 6.9 grados, 9.2 grados, 12.4 grados, 14.8 grados, 16.5 grados, 18.1 grados, 18.5 grados, 19.8 grados, 23.6 grados, 24.9 grados, y 27.7 grados, en donde espectro de difracción de polvo de rayos-X se obtiene al utilizar radiación Cu Ka (?=1.54Å).
MX2023005387A 2017-09-28 2020-07-13 Cristales de maleato de forma-ii de (s)-n2-[1-(4-fluorofenil)etil] -4-(1-metil-1h-pirazol-4-il)-n6-(pirazin-2-il)piridina-2,6-diamin a. MX2023005387A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017187297 2017-09-28

Publications (1)

Publication Number Publication Date
MX2023005387A true MX2023005387A (es) 2023-05-23

Family

ID=65901897

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020007177A MX2020007177A (es) 2017-09-28 2018-09-27 Cristales.
MX2023005387A MX2023005387A (es) 2017-09-28 2020-07-13 Cristales de maleato de forma-ii de (s)-n2-[1-(4-fluorofenil)etil] -4-(1-metil-1h-pirazol-4-il)-n6-(pirazin-2-il)piridina-2,6-diamin a.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2020007177A MX2020007177A (es) 2017-09-28 2018-09-27 Cristales.

Country Status (13)

Country Link
US (1) US11680055B2 (es)
EP (1) EP3689862A4 (es)
JP (2) JPWO2019065793A1 (es)
KR (2) KR20200060418A (es)
CN (2) CN111132971A (es)
AU (2) AU2018338857B2 (es)
BR (1) BR112020005847A2 (es)
CA (1) CA3076803A1 (es)
MX (2) MX2020007177A (es)
MY (1) MY200778A (es)
PH (1) PH12020550139A1 (es)
RU (1) RU2020114659A (es)
WO (1) WO2019065793A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022239068A1 (ja) * 2021-05-10 2022-11-17 日本新薬株式会社 サイトカインストーム抑制剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20140265T1 (hr) 2009-02-06 2014-04-25 Nippon Shinyaku Co., Ltd. Derivat aminopirazina i odgovarajuä†i lijek
JPWO2012005299A1 (ja) * 2010-07-07 2013-09-05 日本新薬株式会社 Ｒｏｓチロシンキナーゼ阻害剤
JPWO2012020786A1 (ja) 2010-08-11 2013-10-28 日本新薬株式会社 医薬組成物
WO2012020787A1 (ja) 2010-08-11 2012-02-16 日本新薬株式会社 悪性リンパ腫治療剤

Also Published As

Publication number Publication date
EP3689862A4 (en) 2021-01-27
US20200223823A1 (en) 2020-07-16
MX2020007177A (es) 2020-10-14
RU2020114659A (ru) 2021-10-28
US11680055B2 (en) 2023-06-20
JP2023105140A (ja) 2023-07-28
JPWO2019065793A1 (ja) 2020-10-22
CN116874467A (zh) 2023-10-13
KR20230142814A (ko) 2023-10-11
CA3076803A1 (en) 2019-04-04
RU2020114659A3 (es) 2022-04-08
AU2018338857A1 (en) 2020-04-16
AU2018338857B2 (en) 2023-05-25
KR20200060418A (ko) 2020-05-29
CN111132971A (zh) 2020-05-08
PH12020550139A1 (en) 2020-12-07
EP3689862A1 (en) 2020-08-05
MY200778A (en) 2024-01-15
AU2023203547A1 (en) 2023-07-06
WO2019065793A1 (ja) 2019-04-04
BR112020005847A2 (pt) 2020-09-29

Similar Documents

Publication Publication Date Title
ZA202100208B (en) Heterocyclic and heteroaryl compounds for treating huntington's disease
MX2020009956A (es) Compuestos para el tratamiento de enfermedad de hungtinton.
MY186531A (en) Crystals
ZA201904234B (en) Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof
EA200971069A1 (ru) Метаболиты производных (тио)карбомоилциклогексана
MY175373A (en) Crystal form of phenylamino pyrimidine derivatives
MX383051B (es) Compuestos que inhiben eif4a y métodos relacionados a los mismos.
ZA202004023B (en) 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors
MX2020007152A (es) Compuestos heterociclicos sustituidos con amina como inhibidores de ehmt2, sales de los mismos, y metodos de sintesis de los mismos.
EA201691242A1 (ru) Фармацевтические композиции, содержащие azd9291
EA202090029A1 (ru) Твердая композиция карипразина для орального введения
PE20161236A1 (es) Compuesto de triazina y su uso para fines medicos
PE20230180A1 (es) Uso de bi853520 en tratamiento contra el cancer
MX2021009659A (es) Hidroxipiridoxazepinas como activadores de nrf2.
EA200901389A1 (ru) Производные фталазина и изохинолина с модулирующим действием на s1p рецепторы
MX2023005387A (es) Cristales de maleato de forma-ii de (s)-n2-[1-(4-fluorofenil)etil] -4-(1-metil-1h-pirazol-4-il)-n6-(pirazin-2-il)piridina-2,6-diamin a.
EA201590250A1 (ru) Производные карбамат/мочевины
PH12021550374A1 (en) Small molecule menin inhibitors
EA201892566A1 (ru) Кристаллический полиморф 15в-гидрокси-осатерона ацетата
MY202100A (en) Crystal
JOP20190279A1 (ar) الصور البلورية من 5-برومو -2، 6-داي (1h-بيرازول -1-يل) بيريميدين -4- أمين وأملاح جديدة
MX2020011070A (es) Formas cristalinas de un compuesto.
CO6270221A2 (es) "forma cristalina 2 de n-[4-(3-amino-1h-indazol-4-il)fenil]-n'-(2-fluoro-5-metilfenil)urea".
MX2020007881A (es) Formas cristalinas del antagonista del receptor cxcr7 acido (3s,4s)-1-ciclopropilmetil-4-{[5-(2,4-difluoro-fenil)-isoxazol-3- carbonil]-amino}-piperidin-3-carboxilico (1-pirimidin-2-il-ciclopr opil)-amida.
NO20083186L (no) Krystallform av vinfluninditartrat